OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.

OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last year. There are currently no approved vaccines to protect against chlamydia – ...

Detailed price information for Orasure Tech Inc (OSUR-Q) from The Globe and Mail including charting and trades.

Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...

Young people aged 15 to 24 are most likely to get chlamydia. Chlamydia can be spread through unprotected sex. Untreated chlamydia may cause serious health problems, especially for people with uteruses ...

Doxycycline postexposure prophylaxis (doxyPEP) involves taking an antibiotic soon after sex without a barrier method to ...

Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

Recent studies in Taiwan show that bacteria and parasites that cause intestinal infections such as Shigella; Giardia; Chlamydia trachomatis, which causes lymphogranuloma venereum (LGV); and Entamoeba ...

Hydreight Technologies Inc. (“Hydreight” or the “Company”), a digital health platform enabling on-demand care, pharmacy fulfillment, and enterprise healthcare services across the United States, today ...